New diabetes drug same price

According to diabetes news, the new diabetes drug Onglyza will cost the same amount as Januvia, the market-leading drug created by Merck. The pricing will plunge the two drugs into direct competition.
Onglyza, made by AstraZeneca and Bristol-Myers Squibb, serves to increase the ability of the body to lower high blood sugar levels. The drug is part of a class of diabetes drugs called DPP-4 inhibitors.
People with diabetes need to maintain average blood glucose levels to lower the risk of complications . Januvia, experts say, will continue to dominate the DPP-4 market. Onglyza was recently approved by the Food and Drug Administratio, the most important stage in bringing new diabetes treatments to market.